Delivery Order SPE2DE24D0013-SPE2D625F6NX3
- Not listed
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,437.57 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, with an ultimate completion date of September 22, 2025. The contract, identified as GXCT/NG-10, carries no set-aside designation and is being performed in Sunnyvale, California, where Cepheid maintains its headquarters. This delivery order represents a continuation of the Department's procurement of molecular diagnostic solutions from Cepheid, a for-profit...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,024 firm fixed-price delivery order to Cepheid Inc. on August 7, 2025, with an ultimate completion date of August 14, 2025. The delivery order, designated XPRSTREPA-10, was issued without a set-aside designation to the Sunnyvale, California-based molecular diagnostics manufacturer. This delivery order represents a continuation of Cepheid's longstanding federal contract relationship, drawing from the company's existing...
- The U.S. Defense Department's Medical Supply Chain awarded a $27,235.80 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, with an ultimate completion date of June 13, 2025. This delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions, specializing in advanced GeneXpert diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 19, 2025, with an ultimate completion date of September 26, 2025. This delivery order, issued under contract XPRS4PLEX-10, carries no set-aside designation and represents a direct procurement of diagnostic solutions from a leading provider of molecular testing technologies. The award draws from...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $13,600 by the Medical Supply Chain, a defense-oriented federal agency, on June 2, 2025. The contract, designated as XPRS4PLEX-10 with completion scheduled for June 9, 2025, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale. This delivery order represents a discrete procurement action within Cepheid's broader...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on June 16, 2025, with an ultimate completion date of June 24, 2025. Cepheid, a for-profit manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. The contract carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility....
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F6NX3Delivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on July 14, 2025, with an ultimate completion date of July 21, 2025. The contract, designated XPRS4PLEX-10, represents a non-set-aside procurement and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order likely draws from one of Cepheid's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts, which enable the company to provide molecular diagnostic solutions on an as-needed basis for federal healthcare systems. Cepheid is a leading manufacturer of molecular diagnostic systems and reagents specializing in infectious disease detection and clinical testing. The company maintains significant relationships with the Department of Veterans Affairs, Defense Logistics Agency, and Defense Health Agency through multiple IDIQ vehicles valued at over $35 million combined. This delivery order aligns with Cepheid's core business of supplying GeneXpert diagnostic systems, test kits, and associated reagents for detecting conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 7/14/25 |